John Mendlein
Director, Monogram Biosciences, Inc.
Companies
- Fate TherapeuticsBoard member Sep 30, 2013 to now1
- Omega Therapeutics, Inc.Board member Jul 29, 2021 to Jun 21, 20242
- aTyr PharmaBoard member May 8, 2015 to May 10, 20193
- ModernaOfficer Dec 7, 2018 to Dec 7, 20184
- aTyr PharmaChief executive officer May 6, 2015 to Sep 5, 20175
- Editas MedicineBoard member Feb 2, 2016 to Jun 19, 20176
- aTyr PharmaOfficer Oct 5, 2015 to Oct 5, 20157
- aTyr PharmaChair May 6, 2015 to May 14, 20155
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARFate Therapeutics, Board member
- 2
- 3SEC EDGARaTyr Pharma, Board member
- 4SEC EDGARModerna, Officer
- 5SEC EDGARaTyr Pharma, Chief executive officer
- 6SEC EDGAREditas Medicine, Board member
- 7SEC EDGARaTyr Pharma, Officer